Sanofi Contingent Value Rights
GCVRZ
GCVRZ was delisted on the 3rd of March, 2020.
124 hedge funds and large institutions have $57.3M invested in Sanofi Contingent Value Rights in 2014 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 27 reducing their positions, and 7 closing their positions.
65% more capital invested
Capital invested by funds: $34.8M → $57.3M (+$22.5M)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
1% less funds holding
Funds holding: 125 → 124 (-1)
59% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 27
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Whitebox Advisors
Minneapolis,
Minnesota
|
+$3.46M |
| 2 |
Allianz Asset Management
Munich,
Germany
|
+$1.02M |
| 3 |
CPM
Chesapeake Partners Management
Baltimore,
Maryland
|
+$1.01M |
| 4 |
GCM
Gruss Capital Management
New York
|
+$447K |
| 5 |
CCA
Catalyst Capital Advisors
Huntington,
New York
|
+$75.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$1.65M |
| 2 |
Millennium Management
New York
|
-$632K |
| 3 |
SAM
Serengeti Asset Management
New York
|
-$543K |
| 4 |
SAM
Silverback Asset Management
Chapel Hill,
North Carolina
|
-$318K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$306K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SC
101
Sophrosyne Capital
New York
| – | -$151K | -488,100 | Closed |
|
|
LTFS
102
Ladenburg Thalmann Financial Services
Miami,
Florida
| – | -$719 | -1,487 | -76% |
|
|
TIM
103
Tortoise Investment Management
White Plains,
New York
| – | +$3 | +7 | New |
|
|
SSB
104
Sandy Spring Bank
Olney,
Maryland
| – | +$5 | +10 | New |
|
105
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | +$7 | +14 | New |
|
|
HDIM
106
Hanson & Doremus Investment Management
Burlington,
Vermont
| – | +$15 | +30 | New |
|
GCVRZ Hedge Fund Activity: Q2 2014 in Review
124 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q2 2014, worth a combined $57.3M — up 65% from $34.8M a quarter earlier.
Fund positioning in GCVRZ was balanced in Q2 2014: 7 funds opened new positions, 7 closed out, 11 added to existing stakes and 27 trimmed.
The largest buyer was Whitebox Advisors, adding an estimated $3.46M. The largest seller was Park West Asset Management, exiting entirely with an estimated $1.65M sold.
- 124 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q2 2014, down from 125 in Q1 2014.
- Funds reported $57.3M of Sanofi Contingent Value Rights stock for Q2 2014, up 65% quarter-over-quarter.
- 7 funds opened new Sanofi Contingent Value Rights positions in Q2 2014 and 7 closed out, a net change of 0 holders.
- The largest Sanofi Contingent Value Rights buyer in Q2 2014 was Whitebox Advisors, an estimated $3.46M added.
- The largest Sanofi Contingent Value Rights seller in Q2 2014 was Park West Asset Management, an estimated $1.65M sold.
Based on aggregated 13F filings for Q2 2014.